Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing

Manufacturing

Welichem enters into termination agreement with Celestial and BWTP Welichem Biotech has entered into a termination agreement with Shenzhen Celestial Pharmaceuticals (Celestial) and Beijing Wenfeng Tianji Pharmaceuticals (BWTP) to terminate the asset purchase agreement dated March 26, 2013 among the parties, pursuant to which the Company agreed to purchase the exclusive development and commercialization rights to the novel anti-inflammatory agent, WBI-1001, in China , Taiwan , Macao and Hong Kong.
Production & Manufacturing > Manufacturing > News
Galmed gets FDA clearance of IND of Armachol to treat fatty liver disorders Galmed Pharmaceuticals, a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones, has announced that the US Food and Drug Administration, or the FDA, cleared its Investigational New Drug (IND) application.
Production & Manufacturing > Manufacturing > News Anavex receives cGMP manufacturing for drug candidate trial supplies By PBR Staff Writer
US-based biopharmaceutical firm Anavex Life Sciences has received cGMP manufacturing of ANAVEX 2-73 for its drug candidate trial supplies.
Production & Manufacturing > Manufacturing > News
See more Manufacturing news

Latest Manufacturing News and Insight

View all Manufacturing news or find news targeted to your interests
Anavex receives cGMP manufacturing for drug candidate trial supplies
By PBR Staff Writer
US-based biopharmaceutical firm Anavex Life Sciences has received cGMP manufacturing of ANAVEX 2-73 for its drug candidate trial supplies.
Production & Manufacturing > Manufacturing > News
Pfizer agrees to buy InnoPharma for $360m
By PBR Staff Writer
Pfizer has entered into an agreement to acquire InnoPharma, a US-based pharmaceutical development company, for $360m.
Production & Manufacturing > Manufacturing > News
Glenmark Pharma to build new manufacturing plant in US
By PBR Staff Writer
Glenmark Pharmaceuticals is planning to build a new manufacturing facility at Monroe Corporate Center, North Carolina, US.
Production & Manufacturing > Manufacturing > News
FDA designates opioid overdose treatment for fast track development program
A Kentucky company headed by a recognized expert in nasal delivery of medication says its intranasal naloxone spray, a drug designed to treat opioid overdoses, has received Fast Track designation from the Food and Drug Administration (FDA).
Production & Manufacturing > Manufacturing > News
Anthera acquires Sollpura for exocrine pancreatic insufficiency from Eli Lilly
Anthera Pharmaceuticals announced that it has acquired Sollpura (liprotamase), a novel investigational Pancreatic Enzyme Replacement Therapy ("PERT") from Eli Lilly and Company.
Production & Manufacturing > Manufacturing > News
Mylan agrees to buy non-US specialty, branded generics assets from Abbott for $5.3bn
By PBR Staff Writer
Generic drug-maker Mylan has entered into a definitive agreement to acquire Abbott's non-US developed markets specialty and branded generics business in an all-stock transaction of $5.3bn.
Production & Manufacturing > Manufacturing > News
ProStrakan agrees to acquire Archimedes Pharma
By PBR Staff Writer
UK-based ProStrakan, a subsidiary of Japanese firm Kyowa Hakko Kirin, has entered into an agreement with Denmark-based Novo to acquire the entire share capital of Archimedes Pharma for a consideration of GBP230m in cash.
Production & Manufacturing > Manufacturing > News
Mariel to acquire Stryker's BMP-7 assets for potential use in osteoarthritis, organ fibrosis
Mariel Therapeutics has entered into a definitive agreement to acquire Stryker Corporation's (SYK) Bone Morphogenetic Protein-7 (BMP-7) assets for the potential treatment of osteoarthritis (OA), chronic kidney disease (CKD) and other organ fibrosis conditions, lupus, and obesity.
Production & Manufacturing > Manufacturing > News
US raises concern over secret trial of two GSK investigators in China
By PBR Staff Writer
The US government has expressed concern after its officials were barred from attending Chinese trial in August of two investigators for British drug-maker GlaxoSmithKline (GSK) who are accused of illegally buying and selling private information.
Production & Manufacturing > Manufacturing > News
Dovobet ointment approved to treat psoriasis vulgaris
Kyowa Hakko Kirin Co., Ltd. (headquarters: Chiyoda-ku, Tokyo; President and CEO: Nobuo Hanai; "Kyowa Hakko Kirin") announced today that LEO Pharma K.K. (headquarters: Chiyoda-ku, Tokyo; General Manager and Japan Representative Director: Stefan Sakurai; "LEO Pharma K.K.") obtained Japanese manufacturing and marketing approval on July 4, 2014 for Dovobet Ointment to treat psoriasis vulgaris.
Production & Manufacturing > Manufacturing > News
View all Manufacturing news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250